ZSCAN2 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 2.399200E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
2.385400E-01
Normal-vs-Stage2
1.247940E-04
Normal-vs-Stage3
5.243400E-03
Normal-vs-Stage4
1.636060E-02
Stage1-vs-Stage2
2.879000E-01
Stage1-vs-Stage3
3.580200E-01
Stage1-vs-Stage4
3.408000E-01
Stage2-vs-Stage3
9.358400E-01
Stage2-vs-Stage4
8.018400E-01
Stage3-vs-Stage4
8.799200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
2.763600E-03
Normal-vs-AfricanAmerican
2.630800E-04
Normal-vs-Asian
6.105900E-02
Caucasian-vs-AfricanAmerican
3.557800E-01
Caucasian-vs-Asian
5.900600E-01
AfricanAmerican-vs-Asian
4.759800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
5.196900E-04
Normal-vs-Female
1.187690E-02
Male-vs-Female
4.142100E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
6.676600E-01
Normal-vs-Age(41-60Yrs)
3.764700E-03
Normal-vs-Age(61-80Yrs)
1.500110E-03
Normal-vs-Age(81-100Yrs)
6.340400E-03
Age(21-40Yrs)-vs-Age(41-60Yrs)
4.855000E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
3.845800E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
1.085980E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
5.872400E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
2.941600E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
9.977400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
4.235200E-04
Normal-vs-Daily Drinker
1.393790E-04
Normal-vs-Weekly Drinker
1.202960E-03
Normal-vs-Occasional Drinker
8.530000E-02
Normal-vs-Social Drinker
6.181800E-03
Non Drinker-vs-Daily Drinker
2.343600E-01
Non Drinker-vs-Weekly Drinker
8.662600E-01
Non Drinker-vs-Occasional Drinker
5.272400E-01
Non Drinker-vs-Social Drinker
4.468400E-01
Daily Drinker-vs-Weekly Drinker
2.417400E-01
Daily Drinker-vs-Occasional Drinker
2.020400E-01
Daily Drinker-vs-Social Drinker
9.534100E-02
Weekly Drinker-vs-Occasional Drinker
6.193600E-01
Weekly Drinker-vs-Social Drinker
6.050200E-01
Occasional Drinker-vs-Social Drinker
9.109200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
8.003800E-01
Normal-vs-Grade 2
8.775600E-01
Normal-vs-Grade 3
9.079600E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
4.947500E-02
Grade 1-vs-Grade 3
9.139500E-02
Grade 1-vs-Grade 4
8.003800E-01
Grade 2-vs-Grade 3
5.623200E-01
Grade 2-vs-Grade 4
8.775600E-01
Grade 3-vs-Grade 4
9.079600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
9.57539999999479E-05
Normal-vs-NonDiabetic
1.147840E-02
Diabetic-vs-NonDiabetic
1.321050E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
2.278200E-02
Normal-vs-NoPancreatitis
6.083600E-03
Pancreatitis-vs-NoPancreatitis
6.257800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
2.536100E-02
Normal-vs-N1
1.768660E-04
N0-vs-N1
2.826000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
2.022400E-03
Normal-vs-TP53-NonMutant
2.409800E-02
TP53-Mutant-vs-TP53-NonMutant
2.219200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
